These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30102818)

  • 21. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
    Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
    Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary transthyretin-related amyloidosis.
    Finsterer J; Iglseder S; Wanschitz J; Topakian R; Löscher WN; Grisold W
    Acta Neurol Scand; 2019 Feb; 139(2):92-105. PubMed ID: 30295933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic tools.
    Kollmer J; Sahm F; Hegenbart U; Purrucker JC; Kimmich C; Schönland SO; Hund E; Heiland S; Hayes JM; Kristen AV; Röcken C; Pham M; Bendszus M; Weiler M
    Neurology; 2017 Aug; 89(5):475-484. PubMed ID: 28679600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of familial amyloid polyneuropathy].
    Adams D; Samuel D; Slama M
    Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
    Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
    J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
    Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R
    Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
    Kollmer J; Hund E; Hornung B; Hegenbart U; Schönland SO; Kimmich C; Kristen AV; Purrucker J; Röcken C; Heiland S; Bendszus M; Pham M
    Brain; 2015 Mar; 138(Pt 3):549-62. PubMed ID: 25526974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?
    Adams D; Beaudonnet G; Adam C; Lacroix C; Théaudin M; Cauquil C; Labeyrie C
    Rev Neurol (Paris); 2016 Oct; 172(10):645-652. PubMed ID: 27663057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
    Schmidt HH; Barroso F; González-Duarte A; Conceição I; Obici L; Keohane D; Amass L
    Muscle Nerve; 2016 Sep; 54(3):353-60. PubMed ID: 27273296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transthyretin Amyloidosis Presenting With Upper-Extremity Neuropathy and Paucity of Autonomic Impairment.
    Devarapalli S; Zhou DJ; Dyck PJB; Piccione EA
    J Clin Neuromuscul Dis; 2019 Jun; 20(4):207-209. PubMed ID: 31135624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
    Lozeron P; Mariani LL; Dodet P; Beaudonnet G; Théaudin M; Adam C; Arnulf B; Adams D
    Neurology; 2018 Jul; 91(2):e143-e152. PubMed ID: 29907605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
    Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M
    J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset.
    Russo M; Mazzeo A; Stancanelli C; Di Leo R; Gentile L; Di Bella G; Minutoli F; Baldari S; Vita G
    J Peripher Nerv Syst; 2012 Dec; 17(4):385-90. PubMed ID: 23279339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transthyretin Amyloid Neuropathy: The Schwann Cell Hypothesis.
    Murakami T; Sunada Y
    Adv Exp Med Biol; 2019; 1190():371-378. PubMed ID: 31760657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validating the usefulness of Sudoscan in ATTRv: a single centre experience.
    Moreno-Moraleda E; González-Moreno J; Cisneros-Barroso E; Ribot-Sansó MA; Ripoll-Vera T; Descals C; Uson M; Montalà JC; Figuerola A; Rodríguez A; Losada I
    Neurol Sci; 2024 Jun; 45(6):2859-2867. PubMed ID: 38261153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound evaluation in transthyretin-related amyloid neuropathy.
    Granata G; Luigetti M; Coraci D; Del Grande A; Romano A; Bisogni G; Bramanti P; Rossini PM; Sabatelli M; Padua L
    Muscle Nerve; 2014 Sep; 50(3):372-6. PubMed ID: 24395461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.
    Koike H; Kawagashira Y; Iijima M; Yamamoto M; Hattori N; Tanaka F; Hirayama M; Ando Y; Ikeda S; Sobue G
    J Neurol; 2008 Oct; 255(10):1526-33. PubMed ID: 18821042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
    Planté-Bordeneuve V; Ferreira A; Lalu T; Zaros C; Lacroix C; Adams D; Said G
    Neurology; 2007 Aug; 69(7):693-8. PubMed ID: 17698792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.
    Dohrn MF; Röcken C; De Bleecker JL; Martin JJ; Vorgerd M; Van den Bergh PY; Ferbert A; Hinderhofer K; Schröder JM; Weis J; Schulz JB; Claeys KG
    J Neurol; 2013 Dec; 260(12):3093-108. PubMed ID: 24101130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.